Aileron Therapeutics : Management Change/Compensation - Form 8-K -March 29, 2024 at 08:05 am EDT

Item 5.02



Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;...

Related Keywords

Michigan ,United States ,Susanl Drexler ,Charles Garner ,Business Assurance Group ,Pricewaterhousecoopers ,Aileron Therapeutics Inc ,Company Senior Vice ,University Of Michigan ,Exchange Commission As Exhibit ,Merchant Banking Group Of Burrill Company ,Board Of Directors The Company ,Danforth Advisors ,Lung Therapeutics Inc ,Company Registration Statement On Form ,Bachelors Of Business Administration ,Recro Pharma Inc ,Certain Officers ,Compensatory Arrangements ,Interim Chief Financial Officer ,Principal Financial Officer ,Principal Accounting ,Aileron Therapeutics ,Separation Date ,Senior Vice President ,Chief Financial Officer ,Lung Therapeutics ,Chief Business Officer ,Recro Pharma ,Merchant Banking Group ,Healthcare Investment Banking Group ,Deutsche Bank ,Business Assurance ,Business Administration ,Exchange Commission ,Registration Statement ,Markets ,